Back to Authors

Van Gerpen, Jay A

Mayo Clinic

Department of Neurology, Mayo Clinic Jacksonville, Florida, 32224.

Citations 22

When DLB, PD, and PSP masquerade as MSA

Neurology | July 3, 2015 | Volume: 85 | Issue: 5 | Pages: 404-412

10.1212/wnl.0000000000001807 | PMID 26138942

A rare sequence variant in intron 1 of THAP1 is associated with primary dystonia

Molecular Genetics & Genomic Medicine | February 12, 2014 | Volume: 2 | Issue: 3 | Pages: 261-272

10.1002/mgg3.67 | PMID 24936516

AbstractAlthough coding variants in THAP1 have been causally associated with primary dystonia, the contribution of noncoding variants remains uncertain. Herein, we examine a previously identified Intron 1 variant (c.71+9C>A, rs200209986). Among 1672 subjects with mainly adult‐onset primary dystonia, 12 harbored the variant in contrast to 1/1574 controls (P < 0.01). Dystonia classification included cervical dystonia (N = 3), laryngeal dystonia (adductor subtype, N = 3), jaw‐opening oromandibular dystonia (N = 1), blepharospasm (N = 2), and unclassified (N = 3). Age of dystonia onset ranged from 25 to 69 years (mean = 54 years). In comparison to controls with no identified THAP1 sequence variants, the c.71+9C>A variant was associated with an elevated ratio of Isoform 1 (NM_018105) to Isoform 2 (NM_199003) in leukocytes. In silico and minigene analyses indicated that c.71+9C>A alters THAP1 splicing. Lymphoblastoid cells harboring the c.71+9C>A variant showed extensive apoptosis with relatively fewer cells in the G2 phase of the cell cycle. Differentially expressed genes from lymphoblastoid cells revealed that the c.71+9C>A variant exerts effects on DNA synthesis, cell growth and proliferation, cell survival, and cytotoxicity. In aggregate, these data indicate that THAP1 c.71+9C>A is a risk factor for adult‐onset primary dystonia.